➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Boehringer Ingelheim
Express Scripts
Mallinckrodt
AstraZeneca

Last Updated: November 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for APD791

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for APD791?

APD791 is an investigational drug.

There have been 4 clinical trials for APD791. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2007.

The most common disease conditions in clinical trials are Acute Coronary Syndrome and [disabled in preview]. The leading clinical trial sponsors are Arena Pharmaceuticals, IlDong Pharmaceutical Co Ltd, and Asan Medical Center.

Recent Clinical Trials for APD791
TitleSponsorPhase
Dose-escalation, Repeated and Single Oral Dosing StudyAsan Medical CenterPhase 1
Dose-escalation, Repeated and Single Oral Dosing StudyIlDong Pharmaceutical Co LtdPhase 1
Safety Study of APD-791 With Aspirin and/or ClopidogrelAsan Medical CenterPhase 1

See all APD791 clinical trials

Clinical Trial Summary for APD791

Top disease conditions for APD791
Top clinical trial sponsors for APD791

See all APD791 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Boehringer Ingelheim
Express Scripts
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.